Search This Blog

Monday, November 4, 2019

Neurocrine Biosciences EPS misses by $0.09, beats on revenue

Neurocrine Biosciences (NASDAQ:NBIX): Q3 GAAP EPS of $0.56 misses by $0.09.
Revenue of $222.09M (+46.4% Y/Y) beats by $10.78M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)